These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 21346508)
1. Academic-industrial relations before the blockbuster drugs: lessons from the Harvard Committee on Pharmacotherapy, 1939-1943. Podolsky SH; Greene JA Acad Med; 2011 Apr; 86(4):496-501. PubMed ID: 21346508 [TBL] [Abstract][Full Text] [Related]
2. The drug industry and clinical research in interwar America: three types of physician collaborator. Rasmussen N Bull Hist Med; 2005; 79(1):50-80. PubMed ID: 15764827 [TBL] [Abstract][Full Text] [Related]
3. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970. Tobbell DA Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387 [TBL] [Abstract][Full Text] [Related]
4. Too friendly? Teaching hospitals revisit ties to pharmaceutical firms. Romano M Mod Healthc; 2003 Jul; 33(28):17. PubMed ID: 12884711 [No Abstract] [Full Text] [Related]
5. Academic-industrial collaboration: the good, the bad, and the ugly. Martin JB Trans Am Clin Climatol Assoc; 2002; 113():227-39; discussion 239-40. PubMed ID: 12053712 [TBL] [Abstract][Full Text] [Related]
6. Relationships between academic institutions and industry in the life sciences--an industry survey. Blumenthal D; Causino N; Campbell E; Louis KS N Engl J Med; 1996 Feb; 334(6):368-73. PubMed ID: 8538709 [TBL] [Abstract][Full Text] [Related]
7. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine. Finkel AG Headache; 2006; 46(7):1181-5. PubMed ID: 16866722 [No Abstract] [Full Text] [Related]
9. Financial conflicts of interest and the ethical obligations of medical school faculty and the profession. Austad K; Brendel DH; Brendel RW Perspect Biol Med; 2010; 53(4):534-44. PubMed ID: 21037407 [TBL] [Abstract][Full Text] [Related]
10. University accused of violating academic freedom to safeguard funding from drug companies. Dyer O BMJ; 2001 Sep; 323(7313):591. PubMed ID: 11557700 [No Abstract] [Full Text] [Related]
11. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry. Tong EK; England L; Glantz SA Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361 [TBL] [Abstract][Full Text] [Related]
12. Conflicts of interest in research: is clinical decision-making compromised? An opinion paper. Adibi S; Bebermeyer RD Tex Dent J; 2010 Aug; 127(8):735-41. PubMed ID: 20945733 [TBL] [Abstract][Full Text] [Related]
13. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
14. Outlook: finding improved medicines: the role of academic-industrial collaboration. Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439 [TBL] [Abstract][Full Text] [Related]
15. Case studies in ethics. The integrity of academic research. Weber LJ; Bissell MG Clin Leadersh Manag Rev; 2001; 15(5):334-5. PubMed ID: 11586925 [No Abstract] [Full Text] [Related]
16. Academia-industry collaboration in continuing medical education: description of two approaches. Katz HP; Goldfinger SE; Fletcher SW J Contin Educ Health Prof; 2002; 22(1):43-54. PubMed ID: 12004640 [TBL] [Abstract][Full Text] [Related]
17. Learning from history: the legacy of Title VII in academic family medicine. Newton W; Arndt JE Acad Med; 2008 Nov; 83(11):1030-8. PubMed ID: 18971653 [TBL] [Abstract][Full Text] [Related]
18. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. Jagsi R; Sheets N; Jankovic A; Motomura AR; Amarnath S; Ubel PA Cancer; 2009 Jun; 115(12):2783-91. PubMed ID: 19434666 [TBL] [Abstract][Full Text] [Related]